Lycan Pharmaceuticals (OPC) Private Limited
About Lycan Pharmaceuticals (OPC) Private Limited
Data last updated:
Lycan Pharmaceuticals (OPC) Private Limited is a one person company based in New Delhi, Delhi, India. It operates in the specialised services segment of the trading and commerce sector. It was incorporated on 04 September 2017 and has been in existence for over 9 years.
The company is registered with the Registrar of Companies (ROC), Delhi, under CIN U51909DL2017OPC323115. Its GSTIN is 07AADCL4002H1ZY (Delhi).
The company has an authorised share capital of ₹1 Lakh and a paid-up capital of ₹1 Lakh. It is led by director Anuj Kumar.
Its last annual general meeting (AGM) was held on 30 September 2019, and its latest financial statements are for the year ended 31 March 2023. The registered office is at Flat No 402 Shriram Bhawan B – 5 Ranjit Nagar Commercial Complex, New Delhi, Delhi, India – 110008.
The current compliance status is marked as compliant by the Registrar of Companies.
Company details
Contact details
Lycan Pharmaceuticals (OPC) Private Limited's registered office is in New Delhi, Delhi. Its e-mail address is in the company report.
- Email
- Registered AddressFlat No 402 Shriram Bhawan B – 5 Ranjit Nagar Commercial Complex, New Delhi, Delhi, India – 110008
- IndustryTrading, Specialty, Wholesale
To see the full contact details of Lycan Pharmaceuticals (OPC) Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Financials of Lycan Pharmaceuticals (OPC) Private Limited
FY 2023 filings availableFinancial Statement Summary
| Metrics | FY 2021-22 | FY 2020-21 | FY 2019-20 | FY 2018-19 | FY 2017-18 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | |||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | |||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2021-22 | FY 2020-21 | FY 2019-20 | FY 2018-19 | FY 2017-18 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | |||||
| Net Profit Margin | |||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Lycan Pharmaceuticals (OPC) Private Limited, buy the company report.
Board of directors of Lycan Pharmaceuticals (OPC) Private Limited
Lycan Pharmaceuticals has 1 director on record. No former directors are listed.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Anuj Kumar | Director | 04 Sep 2017 | 9 Years 2 Months | Current |
Legal cases
No court or tribunal cases involving Lycan Pharmaceuticals (OPC) Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Lycan Pharmaceuticals (OPC) Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
Lycan Pharmaceuticals has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 07AADCL4002H1ZY | Delhi | Active | 15 Sep 2017 |
To see the full GST registrations and return filing status of Lycan Pharmaceuticals (OPC) Private Limited, buy the company report.
Recent activity
Lycan Pharmaceuticals (OPC) Private Limited has 1 board change on record since 2017: 1 appointment. The latest: Anuj Kumar was appointed as Director on 04 Sep 2017.
Frequently asked questions
Lycan Pharmaceuticals is an active company based in New Delhi, Delhi, India. The company works in specialty, within the trading industry. It was incorporated on 04 September 2017 (9+ years old) and is registered under CIN U51909DL2017OPC323115.
Lycan Pharmaceuticals has 1 current director:
- Anuj Kumar - Director
The latest financial statements of Lycan Pharmaceuticals on record with the MCA are for the year ended 31 March 2023. Its last annual general meeting was held on 30 September 2019. Year-wise statements from FY 2018 are in the company report.
The GSTIN of Lycan Pharmaceuticals is 07AADCL4002H1ZY, registered in Delhi.
The CIN (Corporate Identification Number) of Lycan Pharmaceuticals is U51909DL2017OPC323115. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Lycan Pharmaceuticals was incorporated on 04 September 2017, making it 9+ years old. It is registered with the Registrar of Companies, Delhi.
Anuj Kumar was appointed as Director on 04 Sep 2017.
The registered office of Lycan Pharmaceuticals is at Flat No 402 Shriram Bhawan B – 5 Ranjit Nagar Commercial Complex, New Delhi, Delhi, India – 110008.
Lycan Pharmaceuticals operates in the trading industry, in the specialty segment.
The compliance status of Lycan Pharmaceuticals is compliant as of 11 July 2026. The company is actively filing with the Registrar of Companies.
Sample company reports
The same report you get when you buy one: financials, directors, ownership, deals, charges, legal cases, brands and filings, with the Excel workbook alongside.
